Headlands Technologies LLC Vir Biotechnology, Inc. Transaction History

Headlands Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$4.5 - $6.48 $119,331 - $171,836	-26,518 Reduced 94.4%	1,573 $7,000
Q1 2025 May 09, 2025	SELL	$6.48 - $12.48 $28,129 - $54,175	-4,341 Reduced 13.38%	28,091 $182,000
Q4 2024 Feb 12, 2025	BUY	$6.74 - $10.17 $141,432 - $213,407	20,984 Added 183.3%	32,432 $238,000
Q3 2024 Nov 12, 2024	SELL	$7.26 - $10.7 $151,305 - $222,998	-20,841 Reduced 64.55%	11,448 $85,000
Q2 2024 Aug 07, 2024	BUY	$7.63 - $12.66 $156,842 - $260,238	20,556 Added 175.2%	32,289 $287,000

Q1 2024 May 07, 2024	BUY	$8.6 - $11.9 $100,903 - $139,622	11,733 New	11,733 $118,000

243

106M

246K

126K

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $747M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Headlands Technologies LLC with notifications on news.